Table 1.

Changes in Quality-of-life and Arthritis-related Questionnaires From Baseline to 12 Weeks Among 13 Participants With Probable OA

Questionnaire	Baseline	Week 2	Week 4	Week 8	Week 12
VAS-P	4.18 ± 0.61	3.48 ± 0.60	2.68 ± 0.61	1.69 ± 0.58b	1.43 ± 0.68a
MSQ joint/muscle	11.08 ± 1.42	5.15 ± 1.01b	6.00 ± 1.65a	5.62 ± 1.53b	4.69 ± 1.57b
MSQ total	18.38 ± 2.87	9.31 ± 2.18b	8.77 ± 2.27b	9.31 ± 2.68b	7.85 ± 2.05b
MOS-SF36 physical	42.75 ± 3.03	45.55 ± 2.30	46.38 ± 2.71	48.22 ± 2.84a	49.17 ± 2.55a
MOS-SF36 mental	54.64 ± 2.00	56.76 ± 1.66	57.81 ± 1.42	59.05 ± 1.42a	58.78 ± 1.35a
AIQ arthritis symptoms	12.31 ± 0.97	14.08 ± 0.98	15.85 ± 1.18a	18.23 ± 1.12c	18.46 ± 1.30b
AIQ daily living	23.79 ± 2.55	15.95 ± 2.76b	11.67 ± 2.56c	10.09 ± 2.65c	8.36 ± 2.99c
HAQ-DI Q26	60.23 ± 6.47	46.62 ± 6.98	35.62 ± 6.22b	25.41 ± 6.58c	20.54 ± 6.38c
AIMS2	6.08 ± 0.54	5.35 ± 0.47	4.54 ± 0.55	3.54 ± 0.58b	3.27 ± 0.70b

Note: Data are mean ± SE.

Abbreviations: OA, osteoarthritis; SE, standard error of the mean; VAS-P, visual analog scale for pain; MSQ, medical symptoms questionnaire; MOS-SF36, health and wellness outcome questionnaire; AIQ, arthritis impact questionnaire; HAQ-DI Q26, health assessment questionnaire question 26; AIMS2, arthritis impact measurement scales 2.

^aP < .05 compared with baseline.

^bP < .01 compared with baseline.

^cP < .001 compared with baseline.